D.E. Shaw & Co
CNMD icon

D.E. Shaw & Co’s CONMED CNMD Stock Holding History

D.E. Shaw & Co’s Portfolio CNMD Stock Details CNMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-25,000
Closed -$2.22M – 4505
2022
Q4 		$2.22M Hold
25,000
– – ﹤0.01% 2859
2022
Q3 		$2M Buy
+25,000
New +$2.36M ﹤0.01% 3013
2019
Q1 		– Sell
-4,600
Closed -$295K – 3632
2018
Q4 		$295K Hold
4,600
– – ﹤0.01% 3354
2018
Q3 		$364K Buy
+4,600
New +$356K ﹤0.01% 3281

Other funds holding CNMD

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
EARNEST Partners
EARNEST Partners Atlanta, Georgia $24.3B AUM 34.41% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Fuller & Thaler Asset Management
Fuller & Thaler Asset Management San Mateo, California $29.7B AUM 43.33% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
SEI Investments
SEI Investments Oaks, Pennsylvania $108B AUM 26.14% 1-Year Est. Return
CB
Cooke & Bieler Philadelphia, Pennsylvania $8.84B AUM 6.92% 1-Year Est. Return

D.E. Shaw & Co's CNMD Position: Q1 2026 in Review

D.E. Shaw & Co reduced its CONMED (CNMD) stake by 59% in Q1 2026, selling an estimated $2.77M and leaving 47,851 shares worth $1.69M. The position accounts for ﹤0.01% of the portfolio, ranked #3039.

D.E. Shaw & Co first reported a position in CNMD in Q3 2013 and has held it in 35 quarters since. The position peaked at $15.7M in Q4 2014. 236 funds tracked by Wall St. Rank hold CNMD as of Q1 2026.

  • D.E. Shaw & Co held 47,851 shares of CONMED worth $1.69M as of Q1 2026.
  • D.E. Shaw & Co sold 68,150 CONMED shares in Q1 2026, an estimated $2.77M.
  • CONMED made up ﹤0.01% of D.E. Shaw & Co's portfolio in Q1 2026, its #3039 holding.
  • D.E. Shaw & Co first reported a position in CONMED in Q3 2013 and has held it in 35 quarters since.
  • D.E. Shaw & Co's CONMED position peaked at $15.7M in Q4 2014.
  • 236 funds tracked by Wall St. Rank held CONMED as of Q1 2026.

Based on D.E. Shaw & Co's 13F filing for Q1 2026, filed 15 May 2026.